Non-Hodgkin Lymphoma Perspective

• Episode 1: HIV Treatment: How Our Past Informs Our Present   Drs Michael Saag and Paul Volberding kick off this HIV series by exploring major clinical breakthroughs in the history of HIV treatment.
  Medscape, March 01, 2022
• This Is Why Young Academics Are Leaving for Industry Today's academic is less likely to eat crap and call it caviar, and the barrier to leaving is lower than ever before.
  Medscape Oncology, February 24, 2022
• 5 Things to Know About New Pneumococcal Vaccine Guidance Adult pneumococcal vaccine recommendations have been considered some of the most complicated vaccine recommendations to appropriately implement. The good news: Implementation just got simpler.
  CDC Expert Commentary, February 17, 2022
• An Unwelcome Return: Relapsed/Refractory Non-Hodgkin Lymphomas: Designing Plans   Oncologists discuss the expanded therapeutic options for patients with relapsed/refractory NHL and the factors that inform an individualized treatment strategy.
  Medscape TV, February 14, 2022
• Ways to Lessen Toxic Effects of Chemo in Older Adults Dr Hung discusses three recent high-quality randomized trials that evaluated the use of geriatric assessment in older adults with cancer.
  Medscape Family Medicine, February 11, 2022
• How Experiences With Richter Transformation Shaped a Clinician's Day-to-Day Practice   Deborah M. Stephens, DO, shares how the suffering of a family member with CLL inspired her to be an aggressive advocate for getting her patients access to clinical trials and beneficial therapies.
  Medscape, February 11, 2022
• Highlights in Acute Lymphoblastic Leukemia From ASH 2021   Highlights in acute lymphoblastic leukemia from ASH 2021 include pediatric regimens for adults, CNS involvement, and a possible transplant-sparing regimen, as reported by Dr Mark Litzow.
  Medscape, January 10, 2022
• Key Reports in Lymphoma CAR T Therapies From ASH 2021   Key results in CAR T therapies from ASH 2021 focus on shifting from their standard third-line use to second-line use in patients with large B-cell lymphoma, as reported by Dr David Miklos.
  Medscape, January 06, 2022
• An Unwelcome Return: Relapsed/Refractory Non-Hodgkin Lymphomas   Mayo Clinic oncologists discuss the importance of an accurate NHL diagnosis to inform therapy, which includes adding novel targeted agents to standard of care.
  Medscape TV, December 01, 2021
• IWMF 2021 Read clinically focused news coverage of key developments from IWMF 2021
  Medscape Oncology, October 29, 2021
• Managing Rare Non-Hodgkin Lymphomas: Bonus Content: Patient Response   A nurse practitioner and mantle cell lymphoma patient discuss the complexities of navigating oncologic treatment and patient care.
  Medscape TV, October 26, 2021
• Atopic Dermatitis Highlights From AAD Summer Meeting 2021   Dr Jonathan Silverberg discusses key reports on atopic dermatitis from AAD 2021, including data on dupilumab and how biologic therapies affect CTCL risk. He also reports on emerging agents.
  Medscape, August 25, 2021
• Uncommon Malignancies: Managing Rare Non-Hodgkin Lymphomas: Aggressive but Curable   Oncologists discuss the importance of distinguishing between the rare Burkitt lymphoma and diffuse large B-cell lymphoma, because the treatment regimens differ.
  Medscape TV, August 04, 2021
• Cancer Therapy and Myocardial Dysfunction: 5 Things to Know An expert overview of some key aspects to preventing, monitoring, and managing cardiac dysfunction related to cancer therapy.
  American College of Cardiology & Medscape , July 26, 2021
• Diagnostic Technology Is Great...Until It Isn't Cutting-edge diagnostics are miracles of modern medicine, but their help can come at a high price.
  Medscape Blogs, July 20, 2021
• EHA 2021 Read clinically focused news coverage of key developments from EHA 2021
  Medscape Oncology, June 11, 2021
• Uncommon Malignancies: Managing Rare Non-Hodgkin Lymphomas: A Lasting Response   The oncologists discuss criteria for recommending a more aggressive approach in the treatment of mantle cell lymphoma, including stem cell transplant.
  Medscape TV, May 24, 2021
• Uncommon Malignancies: Managing Rare Non-Hodgkin Lymphomas: Diverse Presentation of MCL   Oncologists discuss the symptoms of aggressive mantle cell lymphoma and the usefulness of MIPI scores to gauge risk and guide frontline treatment decisions.
  Medscape TV, April 09, 2021
• MGUS, SPEP, and the Shaka Sign   With the right threshold of suspicion, a patient's life may be saved.
  The Curbsiders, February 05, 2021
• Uncommon Malignancies: Managing Rare Non-Hodgkin Lymphomas: Indolent but Incurable   Oncologists report on when to initiate therapy in Waldenstrom macroglobulinemia and the multiple, effective chemo-immunotherapy options available.
  Medscape TV, January 21, 2021